Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 1148-1154, March 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pera, P. J.
Right arrow Articles by Porter, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pera, P. J.
Right arrow Articles by Porter, C. W.

Comparison of the Biological Effects of Four Irreversible Inhibitors of Ornithine Decarboxylase in Two Murine Lymphocytic Leukemia Cell Lines1

Paula J. Pera, Debora L. Kramer2, Janice R. Sufrin and Carl W. Porter3

Grace Cancer Drug Center [D. L. K., P. J. P., C. W. P., J. R. S.] and Department of Surgical Oncology [J. R. S.], Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14263

The effects of the enzyme-activated irreversible inhibitors of ornithine decarboxylase, {alpha}-difluoromethylornithine, {alpha}-(fluoromethyl)dehydroornithine, {alpha}-(fluoromethyl)dehydroornithine methyl ester, and (2R,5R)-6-heptyne-2,5-diamine (RR-MAP), on cell growth and parameters related to polyamine biosynthesis were compared in L5178Y and L1210 cells under identical culture conditions. The two lines are murine lymphocytic leukemia cells which differ in their ability to metabolize 5'-methylthioadenosine, the by-product of polyamine biosynthesis: L5178Y cells contain a specific 5'-methylthioadenosine phosphorylase; L1210 cells do not. In L1210 cells, the 50% inhibitory concentrations (IC50s) of the various analogues were 3.0 mM for {alpha}-difluoromethylornithine, 0.2 mM for {alpha}-(fluoromethyl)dehydroornithine, 0.1 mM for {alpha}-(fluoromethyl)dehydroornithine methyl ester, and 0.01 mM for RR-MAP. L5178Y cells were somewhat more sensitive to the inhibitors with IC50 values of 0.5 mM for {alpha}-difluoromethylornithine, 0.06 mM for {alpha}-(fluoromethyl)dehydroornithine, 0.03 mM for {alpha}-(fluoromethyl)dehydroornithine methyl ester, and 0.002 mM for RR-MAP. In all cases, growth inhibition was fully prevented by exogenous putrescine. The effects of the inhibitors on parameters related to polyamine metabolism were compared at drug concentrations approximating the average of IC50 values for the two cell lines. Under these treatment conditions, polyamine pools were similarly affected by the various inhibitors. Typically, putrescine and spermidine were depleted, but effects on spermine pools differed according to the cell line, increasing slightly in L1210 cells and decreasing by about 50% in L5178Y cells. Spermine pools in L1210 cells could be reduced by RR-MAP at concentrations higher than the IC50 (i.e., 0.1 mM). Clonogenicity in soft agar was decreased about 50% by putrescine and spermidine depletion and was not further affected by spermine depletion. The inhibitors elevated S-adenosylmethionine decarboxylase activity in both cell lines with a 2-fold greater increase in L5178Y cells than in L1210 cells. Finally, the inhibitors decreased S-adenosylmethionine pools in L1210 cells by about 50% but had little effect on these pools in L5178Y cells with the exception of RR-MAP, which decreased S-adenosylmethionine pools by about 40%. Whether the different polyamine responses of the two cell lines are related to their ability to metabolize 5'-methylthioadenosine is uncertain. It is apparent, however, that the presence or absence of methylthioadenosine phosphorylase does not substantially modulate the antiproliferative activity of ornithine decarboxylase inhibitors. With respect to the new inhibitors of ornithine decarboxylase, the putrescine analogue, RR-MAP, was clearly more effective than the ornithine analogues in depleting intracellular polyamines and in inhibiting cell growth.

1 This investigation was supported by Research Grants CA-22153, CA-33321, and CA-37606; Program Grant CA-13038; and Core Grant CA-24538 from the National Cancer Institute, Department of Health, Education, and Welfare.

2 Recipient of support as a postdoctoral fellow by NIH Training Grant CA-09072.

3 To whom requests for reprints should be addressed.

Received 7/24/85. Revised 11/ 5/85. Accepted 11/ 7/85.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. Saminathan, T. Thomas, A. Shirahata, C. K. S. Pillai, and T. J. Thomas
Polyamine structural effects on the induction and stabilization of liquid crystalline DNA: potential applications to DNA packaging, gene therapy and polyamine therapeutics
Nucleic Acids Res., September 1, 2002; 30(17): 3722 - 3731.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.